Ledger.Open graph →
SEC Form D · Amendment · filed December 10, 2025

Ansa Biotechnologies, Inc

Offering
$56.9M
Sold
$46.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Yanniv T. Dorone · Emeryville, CADirectorDaniel T. Lin-Arlow · Emeryville, CAExec · DirectorChenny T. Zhang · Emeryville, CADirectorJason T. Gammack · Emeryville, CAExec · DirectorSebastian T. Palluk · Emeryville, CAExecMatthew T. Mcmanus · Emeryville, CADirectorJason T. Gammack · Emeryville, CAExec · DirectorYanniv T. Dorone · Emeryville, CADirectorMatthew T. Mcmanus · Emeryville, CADirectorYmir Vigfusson · DOVER, DEExecRichard Chesney · Dallas, TXExec · DirectorChenny T. Zhang · Emeryville, CADirectorNewton Howard · FRISCO, TXExec · DirectorRobert V. Delaney, Jr · New York, NYExecMichael E. West · New York, NYExec · DirectorAndreh Kalatizadeh · Kew Gardens, NYDirectorAlen Kalati · Springfield, NJDirectorDavid Benhaim · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗